Amundi Novo Nordisk A S Transaction History

Amundi

$275 Billion
Q1 2025

A detailed history of Amundi transactions in Novo Nordisk A S stock. As of the latest transaction made, Amundi holds 4,938,507 shares of NVO stock, worth $348 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

4,938,507

Previous 3,311,456 49.13%

Holding current value

$348 Million

Previous $285 Million 20.39%

% of portfolio

0.12%

Previous 0.1%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$69.3 - $90.95 $113 Million - $148 Million	1,627,051 Added 49.13%	4,938,507 $343 Million
Q4 2024 Feb 07, 2025	BUY	$85.0 - $120.04 $58.9 Million - $83.1 Million	692,567 Added 26.45%	3,311,456 $285 Million
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $33.4 Million - $40.8 Million	280,325 Added 11.99%	2,618,889 $312 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $21.6 Million - $25.8 Million	175,951 Added 8.14%	2,338,564 $334 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $68.6 Million - $91.3 Million	671,375 Added 45.02%	2,162,613 $278 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $119 Million - $143 Million	1,359,388 Added 1031.01%	1,491,238 $154 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $3.77 Million - $8.28 Million	41,486 Added 45.91%	131,850 $12 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $11 Million - $12.2 Million	-70,840 Reduced 43.94%	90,364 $14.6 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $20.6 Million - $24.8 Million	-155,595 Reduced 49.11%	161,204 $25.7 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $268,783 - $354,699	-2,621 Reduced 0.82%	316,799 $42.9 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $2.67 Million - $3.28 Million	-28,066 Reduced 8.08%	319,420 $33.9 Million
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $6.33 Million - $7.46 Million	-61,269 Reduced 14.99%	347,486 $38 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $124,195 - $150,128	1,334 Added 0.33%	408,755 $49.8 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $441,143 - $538,685	4,601 Added 1.14%	407,421 $40.6 Million
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $11.5 Million - $14.6 Million	-136,526 Reduced 25.31%	402,820 $38.7 Million
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $36.5 Million - $45.7 Million	539,346 New	539,346 $45.2 Million

Others Institutions Holding NVO

# of Institutions

1,768

Shares Held

330M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $159B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account